Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
about
CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to boneBone antiresorptive agents in the treatment of bone metastases associated with solid tumours or multiple myelomaThe reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22Prostate cancer invasion and metastasis: insights from mining genomic data.Future of bisphosphonates and denosumab for men with advanced prostate cancer.Comparison of the efficacy and safety of denosumab versus bisphosphonates in breast cancer and bone metastases treatment: A meta-analysis of randomized controlled trials.Direct antitumour activity of zoledronic acid: preclinical and clinical data.The good pain management (GPM) ward program in China and its impact on Chinese cancer patients: the SYSUCC experience.A cross-sectional survey of the diagnosis and management of bone metastasis in breast cancer patients in TurkeyLongitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destructionEffect of zoledronate on oral wound healing in rats.Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cellsZoledronic Acid may reduce intraoperative bleeding in spinal tumors: a prospective cohort studyOsteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection.Bisphosphonate therapy in multiple myeloma in preventing vertebral collapses: preliminary report.Cancer Pain Management and Bone Metastases: An Update for the Clinician.Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the artDihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts.The Italian cross-sectional survey of the management of bone metastasis: ZeTa study.Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases.Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists.Does CT-based Rigidity Analysis Influence Clinical Decision-making in Simulations of Metastatic Bone Disease?Painful boney metastases.Emerging therapeutic targets in breast cancer bone metastasis.Steps in prostate cancer progression that lead to bone metastasisBisphosphonates as radionuclide carriers for imaging or systemic therapy.Implication of platelet-derived growth factor receptor alpha in prostate cancer skeletal metastasisDenosumab and the current status of bone-modifying drugs in breast cancer.Bone homeostasis and breast cancer: implications for complex therapy and the maintenance of bone integrity.Use of bisphosphonates in metastatic breast cancer: single institution review at the Dr. H. Bliss Murphy Cancer Centre.Zoledronic acid in genitourinary cancer.Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trials.Breast cancer and bone metastases: the association of axial skeleton MRI findings with skeletal-related events and survival.The critical role of bisphosphonates to target bone cancer metastasis: an overview.Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial.Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling.Radiopharmaceuticals for metastatic bone pain palliation: available options in the clinical domain and their comparisons.Pain in castration-resistant prostate cancer with bone metastases: a qualitative study.The natural compound Alizarin as an osteotropic drug for the treatment of bone tumors.Bone metastasis in a novel breast cancer mouse model containing human breast and human bone.
P2860
Q24609211-C07FA632-8407-4305-A6DC-85A313BD4B7AQ28081996-F1940CF4-7453-4DFB-84C2-4F2B63A01054Q28303771-BCA80CB5-6530-49C6-B3D0-4FFD7F5DFBF7Q30656758-790CB705-F25F-4D0C-A7D4-2CD46DBF917CQ33583525-E8B68B83-DFF0-4FC2-B52D-4A427B0C71CAQ33727640-DC1C09A6-336D-41E8-8EAC-373662911FE9Q33850938-0984EDED-DF71-4F24-81AE-0646EF027206Q33947848-BDCA0F14-3E4A-4F0C-AC0B-D68AE0D34BE8Q34130479-637B3BE4-B8AC-4DD0-A8E8-3F5CE5E5AA10Q34284100-FF33261C-7676-430C-B831-CC45DBF1FB9DQ34694368-46CB0178-947D-4E32-9B1E-4D696A49C843Q34967135-FA7173C0-33E8-4EC4-B3A5-954E1D0B13D8Q35050733-681A3B86-B76B-46F0-B7E2-B82EF960A789Q35572441-BFC69AF6-A6EF-4FE7-B283-DCA1E74459F6Q35886257-263568E1-854A-42A9-A784-3E94C71B46D0Q36036131-38D23D9C-6BB2-49FB-8EC7-63BB8201FBEAQ36278556-E4D16A20-48E7-4C08-93B9-785CBBF33387Q36442668-402D0B3F-8EDA-428E-975E-4A5F6556B190Q36491369-59917691-FC70-41B6-8C4D-81CADD9AD479Q36510928-32288B09-DEA1-423D-98B8-513317910EAAQ36558056-6A7C3CCD-4EE4-48BF-8F5B-7F1B79F82BC6Q36558754-35827FA7-5357-414E-9F13-CF1B36AE208EQ37011060-33D8D66B-E9BD-4182-8674-C6CC035FD054Q37658767-76C65D2F-FFF8-4938-92C6-807C99EC940BQ37848782-ECEEA3B7-6A76-4F9B-B63C-476352BBCD09Q37924117-A946B616-E3F4-42F3-AFEB-814BBA1E8992Q37924342-888C4E45-7448-4AFE-99C0-F71A75322DFDQ37965768-B950C97A-701C-4974-8AA7-0A24A7F316B1Q38065098-32A9B295-A131-497A-BE83-4E6817AD734DQ38075447-33C49CD1-9ADD-4418-8075-9E64BDDA692FQ38101500-6F9B7168-1272-4D88-942A-6EF0BF6515D6Q38162877-DD4CA80A-71B1-443E-AB0E-9A98C6834DC3Q38227713-A0A42791-9457-457C-BB88-6C62209487DFQ38247428-528653C7-86EB-4A4D-94EA-0A90BC4A2322Q38381733-8D52A78C-8A05-4239-855B-FA2584B452E1Q39028702-CBA697CE-1A69-4542-A5C8-8CBA87497B59Q39042390-8DBD7373-B05D-4804-A57B-61AD4495434FQ39322019-90E5657E-1F17-41DC-841C-BDFF6B167CEDQ39381046-5E98152E-8A8C-4250-BE9E-27145A6C7FD5Q39531184-3B7C1C77-D281-416D-BDD8-FCF8F24545A6
P2860
Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
@ast
Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
@en
Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
@nl
type
label
Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
@ast
Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
@en
Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
@nl
prefLabel
Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
@ast
Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
@en
Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
@nl
P2860
P356
P1476
Effect of bisphosphonates on pain and quality of life in patients with bone metastases.
@en
P2093
Pierre P Major
P2860
P304
P356
10.1038/NCPONC1323
P50
P577
2009-02-03T00:00:00Z